-
PROVIDERS
New MRD Medicare Coverage for Select Indications*
*When coverage criteria are met. Additional criteria and exceptions for coverage may apply.
-
LIFE SCIENCES
REGISTER NOW
UPCOMING WEBINAR
A new era of Biopharma R&D: The TechBio revolution – Realities and the next frontier -
PATIENTS
It's About Time
View the Tempus vision.
- RESOURCES
-
ABOUT US
View Job Postings
We’re looking for people who can change the world.
- INVESTORS
Resources
Webinars
-
11/06/2025Beyond imaging: Leveraging molecular tools to detect MRD for personalized cancer care
This webinar explores the clinical value of MRD testing and IO treatment response monitoring in oncology, using real-world cases to illustrate its application in patient management.Speakers:
Watch replay -
10/21/2025How to reduce your documentation burden with AI
Discover how an AI-powered clinical notetaker can reduce documentation stress and add time back into your day.Speakers:
Watch replay -
10/01/2025Uncovering the uncommon in rare cancers: Diagnostic innovation driving change
Experts highlight how integrating AI and multimodal data can uncover deeper insights in rare cancers, enhance trial opportunities, and inform treatment strategies.Speakers: Ezra Cohen,
Watch replay
Chief Medical Officer of Oncology, Tempus,
Razelle Kurzrock, MD, FACP
Center Associate Director, Professor of Medical College of Wisconsin
-
09/15/2025AI in oncology: Fundamentals to full integration into your practice
Explore Tempus’ latest advancements in artificial intelligence and how it is being applied in real-world oncology settings with Drs. Sanjay Juneja and Debra Patt.Speakers: Sanjay Juneja, MD
Watch replay
Vice President of Clinical AI Operations, Tempus
Debra Patt, MD, PhD, MBA
Executive Vice President Policy and Strategy,
Texas Oncology
-
08/12/2025What’s next in oncology: Research breakthroughs from the 2025 ASCO® annual meeting
Explore key research and clinical insights from the 2025 ASCO® Annual Meeting, featuring expert analysis from Drs. Ezra Cohen, Sara Tolaney, Nataliya Uboha, and Cynthia Ma.Speakers: Ezra Cohen,
Watch replay
Chief Medical Officer of Oncology, Tempus,
Cynthia X. Ma, MD, PhD
Professor, Medicine, Division of Oncology at Washington University School of Medicine
Nataliya Uboha, MD, PhD
Faculty Leader for Early Phase Oncology Therapeutics Program, Associate Professor, Department of Medicine, Section of Hematology & Oncology, University of Wisconsin
Sara Tolaney,
Chief of the Division of Breast Oncology at Dana-Farber Cancer Institute, Associate Professor of Medicine at Harvard Medical School -
07/29/2025Navigating new frontiers in breast care gap closure: the role of providers and AI
A deep dive into Tempus Next's impact on precision medicine.Speakers:
Watch replay -
07/14/2025Closing care gaps with AI: The next competitive edge in pharma
Expert perspectives on advancing adherence to precision medicine guidelines.Speakers: Ryan Fukushima,
Watch replay
COO, Tempus
Gary Grad,
MD Senior Medical Oncologist, Medical Science, Tempus
Ahmed ElNawawi,
Head of US Commercial Organization, Menarini Stemline -
05/31/2025Industry Expert Theater Presentation* from the 2025 ASCO® Annual Meeting
Powering today’s insights for a smarter tomorrow: Intelligent diagnostics and AI solutions across the cancer continuum.Speakers: Ezra Cohen, MD, FASCO
Watch replay
Chief Medical Officer of Oncology, Tempus
Kate Sasser, PhD
Chief Scientific Officer, Tempus
Halla Nimeiri, MD
Chief Development Officer, Tempus
-
06/12/2025AI & ML in action: Demonstrating real-world impact in trial design & patient care
Discover how the Tempus platform leverages AI and ML to inform standard of care practices through health equity guidelines and drive insights that help refine clinical trial design.Speakers: Jonathan Ozeran
Watch replay
VP Generative AI, Tempus
Chris Scotto DiVetta
SVP & General Manager of AI Applications -
03/25/2025The RNA advantage: A multimodal approach to accelerating oncology R&D
Discover how transcriptomic data and multi-omics data integrated with AI is helping revolutionize oncology drug development and patient care and fueling precision medicine 2.0. Learn about RNA sequencing’s role in companion diagnostics and Tempus Loop’s capabilities to support target identification and validation.Speakers: Internal:
Watch replay
Justin Guinney, PhD
SVP of Cancer Genomics, Tempus
External:
Rafael Rosengarten, PhD
CEO & Co-founder, Genialis
Sadnip Patel, MD
Professor of Medical Oncology, UC San Diego